NUVL Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Buy

72

4 7 16

Oscillators

Neutral

50

4 2 4

Moving averages

Strong Buy

85

0 5 12

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 6, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$9.79B

Growth and income

Eps-6.06

Free Cash Flow$-180.43M

Net Income$-109.28M

Profitability

Ebitda$-119.41M

Balance sheet

Free Cash Flow$-180.43M

Total Assets$1.33B

Total Liabilities$156.78M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

PTGXPROTAGONIST THERAPEUTICS INC+0.00%Residual co-movement · Market co-movement XNCRXENCOR INC+0.00%Residual co-movement · Market co-movement CLDXCELLDEX THERAPEUTICS INC+0.00%Residual co-movement · Market co-movement PCVXVAXCYTE INC+0.00%Residual co-movement · Market co-movement FDMT4D MOLECULAR THERAPEUTICS IN+0.00%Residual co-movement · Market co-movement

RelationshipsLoading

NUVALENT INC A

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships